TY - JOUR
T1 - Extracellular HSP27 mediates angiogenesis through Toll-like receptor 3
AU - Thuringer, Dominique
AU - Jego, Gaetan
AU - Wettstein, Guillaume
AU - Terrier, Olivier
AU - Cronier, Laurent
AU - Yousfi, Nadhir
AU - Hébrard, Sophie
AU - Bouchot, André
AU - Hazoumé, Adonis
AU - Joly, Anne Laure
AU - Gleave, Martin
AU - Rosa-Calatrava, Manuel
AU - Solary, Eric
AU - Garrido, Carmen
PY - 2013/10/1
Y1 - 2013/10/1
N2 - The heat-shock protein 27 (HSP27) is up-regulated in tumor cells and released in their microenvironment. Here, we show that extracellular HSP27 has a proangiogenic effect evidenced on chick chorioallantoic membrane. To explore this effect, we test the recombinant human protein (rhHSP27) at physiopathological doses (0.1-10 μg/ml) onto human microvascular endothelial cells (HMECs) grown as monolayers or spheroids. When added onto HMECs, rhHSP27 dosedependently accelerates cell migration (with a peak at 5 μg/ml) and favors spheroid sprouting within 12-24 h. rhHSP27 increases VEGF gene transcription and promotes secretion of VEGF-activating VEGF receptor type 2. Increased VEGF transcription is related to NF-κB activation in 30 min. All of these effects are initiated by rhHSP27 interaction with Toll-like receptor 3 (TLR3). Such an interaction can be detected by immunoprecipitation but does not seem to be direct, as we failed to detect an interaction between rhHSP27 and monomeric TLR3 by SPR analysis. rhHSP27 is rapidly internalized with a pool of TLR3 to the endosomal compartment (within 15-30 min), which is required for NF-kB activation in a cytosolic Ca2+ dependent manner. The HSP27/TLR3 interaction induces NF-κB activation, leading to VEGF-mediated cell migration and angiogenesis. Such a pathway provides alternative targets for antiangiogenic cancer therapy.
AB - The heat-shock protein 27 (HSP27) is up-regulated in tumor cells and released in their microenvironment. Here, we show that extracellular HSP27 has a proangiogenic effect evidenced on chick chorioallantoic membrane. To explore this effect, we test the recombinant human protein (rhHSP27) at physiopathological doses (0.1-10 μg/ml) onto human microvascular endothelial cells (HMECs) grown as monolayers or spheroids. When added onto HMECs, rhHSP27 dosedependently accelerates cell migration (with a peak at 5 μg/ml) and favors spheroid sprouting within 12-24 h. rhHSP27 increases VEGF gene transcription and promotes secretion of VEGF-activating VEGF receptor type 2. Increased VEGF transcription is related to NF-κB activation in 30 min. All of these effects are initiated by rhHSP27 interaction with Toll-like receptor 3 (TLR3). Such an interaction can be detected by immunoprecipitation but does not seem to be direct, as we failed to detect an interaction between rhHSP27 and monomeric TLR3 by SPR analysis. rhHSP27 is rapidly internalized with a pool of TLR3 to the endosomal compartment (within 15-30 min), which is required for NF-kB activation in a cytosolic Ca2+ dependent manner. The HSP27/TLR3 interaction induces NF-κB activation, leading to VEGF-mediated cell migration and angiogenesis. Such a pathway provides alternative targets for antiangiogenic cancer therapy.
KW - Autocrine VEGFR2 activation
KW - Chorioallantoic membrane
KW - Endocytosis
KW - Microvascular endothelial cell
KW - NF-κB pathway
KW - Tubulogenesis
KW - VEGF release
UR - http://www.scopus.com/inward/record.url?scp=84885135776&partnerID=8YFLogxK
U2 - 10.1096/fj.12-226977
DO - 10.1096/fj.12-226977
M3 - Article
C2 - 23804239
AN - SCOPUS:84885135776
SN - 0892-6638
VL - 27
SP - 4169
EP - 4183
JO - FASEB Journal
JF - FASEB Journal
IS - 10
ER -